Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recs

0
Player Avatar crossmpls007 (63.07) Submitted: 11/5/2010 2:46:57 PM : Outperform Start Price: $54.12 AMGN Score: +19.25

hunch

Report this Post Reply

Featured Broker Partners


Advertisement